Related Experiment Video
Updated: Mar 13, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
Donald P Rice1, John J Faragon2, Sarah Banks3
1Division of Infectious Diseases, Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA.
Abstract:
Therapy for human immunodeficiency virus (HIV) and chronic hepatitis C has evolved over the past decade, resulting in better control of infection and clinical outcomes; however, drug-drug interactions remain a significant hazard. Joint recommendations from the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America regarding drug-drug interactions between HIV antiretroviral agents and direct-acting antiviral agents for treatment of hepatitis C virus (HCV) infection are reviewed here. This review is oriented to facilitate appropriate selection of an antiviral therapy regimen for HCV infection based on the choice of antiretroviral therapy being administered and, if necessary, switching antiretroviral regimens.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacokinetics: Drug–Drug Interactions
Retroviruses
Antihypertensive Drugs: Direct Renin Inhibitors

